News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Solvay Pharmaceuticals, Inc. Scratches Plan for $300 Million Birmingham Plant
October 1, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Solvay Pharmaceuticals Inc. has scrapped plans to build a $300 million flu drug plant which Birmingham Mayor Larry Langford said was destined for the city.
Twitter
LinkedIn
Facebook
Email
Print
Real estate
MORE ON THIS TOPIC
Huntington’s disease
Roche scraps 2 Huntington’s studies, handing Ionis more bad news
July 10, 2026
·
2 min read
·
Tristan Manalac
Artificial intelligence
Biopharma R&D needs ‘structural redesign’ to maximize AI impact: report
July 9, 2026
·
2 min read
·
Nick Paul Taylor
Neurodegenerative disease
GSK abandons Alector after back-to-back neuro stumbles
July 9, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
Tanabe pens deal to sell plants to Towa in post-buyout pivot
July 8, 2026
·
2 min read
·
Nick Paul Taylor
